tirzepatide and perimenopause Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Tirzepatide for Peri Weight: Microdosing

We have been using this medication off-label for a few years, and are pleased that it is now FDA approved as of June 4, 2021

You should avoid both Ozempic (semaglutide) and tirzepatide while breastfeeding due to insufficient human safety data, though emerging evidence suggests sema...

AFC Urgent Care Castle Rock Castle Rock provides weight management services in Castle Rock, CO

Free download from Old Bull Health

### Funding Statement This study did not receive any external funding

Combining GLP-1 receptor agonists like semaglutide with selective serotonin reuptake inhibitors such as Zoloft requires careful monitoring and medical oversight